Rational design for novel heterocyclic based Donepezil analogs for Alzheimer’s disease: an in silico approach

References

• Akrami, H., Mirjalili, B. F., Khoobi, M., Nadri, H., Moradi, A., Sakhteman, A., Emami, S., Foroumadi, A., & Shafiee, A. (2014). Indolinone-based acetylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling. European Journal of Medicinal Chemistry, 84, 375–381. https://doi.org/10.1016/j.ejmech.2014.01.017
   PubMed Web of Science ®Google Scholar
• Aljohani, G., Al-Sheikh Ali, A., Alraqa, S. Y., Itri Amran, S., & Basar, N. (2021). Synthesis, molecular docking and biochemical analysis of aminoalkylated naphthalene-based chalcones as acetylcholinesterase inhibitors. Journal of Taibah University for Science, 15(1), 781–797. https://doi.org/10.1080/16583655.2021.2005921
   Web of Science ®Google Scholar
• Baharloo, F., Moslemin, M. H., Nadri, H., Asadipour, A., Mahdavi, M., Emami, S., Firoozpour, L., Mohebat, R., Shafiee, A., & Foroumadi, A. (2015). Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry, 93, 196–201. https://doi.org/10.1016/j.ejmech.2015.02.009
   PubMed Web of Science ®Google Scholar
• Bajda, M., Więckowska, A., Hebda, M., Guzior, N., Sotriffer, C. A., & Malawska, B. (2013). Structure-based search for new inhibitors of cholinesterases. International Journal of Molecular Sciences, 14(3), 5608–5632. https://doi.org/10.3390/ijms14035608
   PubMed Web of Science ®Google Scholar
• Barreiro, E. J., Camara, C. A., Verli, H., Brazil-Más, L., Castro, N. G., Cintra, W. M., Aracava, Y., Rodrigues, C. R., & Fraga, C. A. M. (2003). Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: A new class of potent and selective acetylcholinesterase inhibitors. Journal of Medicinal Chemistry, 46(7), 1144–1152. https://doi.org/10.1021/jm020391n
   PubMed Web of Science ®Google Scholar
• Bautista-Aguilera, O. M., Esteban, G., Bolea, I., Nikolic, K., Agbaba, D., MORaleda, I., Iriepa, I., Samadi, A., Soriano, E., Unzeta, M., & Marco-Contelles, J. (2014). Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry, 75, 82–95. https://doi.org/10.1016/j.ejmech.2013.12.028
   PubMed Web of Science ®Google Scholar
• Becke, A. D. (1993). Density-functional thermochemistry. III. The role of exact exchange. The Journal of Chemical Physics, 98(7), 5648–5652. https://doi.org/10.1063/1.464913
   Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Blennow, K., de Leon, M. J., & Zetterberg, H. (2006). Alzheimer’s disease. Lancet (London, England), 368(9533), 387–403. https://doi.org/10.1016/S0140-6736(06)69113-7
   PubMed Web of Science ®Google Scholar
• Bullock, R., Touchon, J., Bergman, H., Gambina, G., He, Y., Rapatz, G., Nagel, J., & Lane, R. (2005). Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer’s disease over a 2-year period. Current Medical Research and Opinion, 21(8), 1317–1327. https://doi.org/10.1185/030079905X56565
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. Journal of Chemical Physics. 126(1), 014101.
   PubMed Web of Science ®Google Scholar
• Camps, P., Formosa, X., Galdeano, C., Gómez, T., Muñoz-Torrero, D., ScarpeLLini, M., Viayna, E., Badia, A., Clos, M. V., Camins, A., Pallàs, M., BaRTolini, M., Mancini, F., Andrisano, V., Estelrich, J., Lizondo, M., Bidon-Chanal, A., & Luque, F. J. (2008). Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation. Journal of Medicinal Chemistry, 51(12), 3588–3598. https://doi.org/10.1021/jm8001313
   PubMed Web of Science ®Google Scholar
• Rodrigues Simões, M. C., Dias Viegas, F. P., Moreira, M. S., de Freitas Silva, M., Riquiel, M. M., da Rosa, P. M., Castelli, M. R., dos SaNTos, M. H., Soares, M. G., & Viegas, C. (2014). Donepezil: An important prototype to the design of new drug candidates for Alzheimer’s disease. Mini Reviews in Medicinal Chemistry, 14(1), 2–19. https://doi.org/10.2174/1389557513666131119201353
   PubMed Web of Science ®Google Scholar
• Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., Franklin, M. C., & Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55(22), 10282–10286. https://doi.org/10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• Choubey, P. K., Tripathi, A., Sharma, P., & Shrivastava, S. K. (2020). Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry, 28(22), 115721. https://doi.org/10.1016/j.bmc.2020.115721
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Dartigues, J. F. (2009). Alzheimer’s disease: A global challenge for the 21st century. The Lancet. Neurology, 8(12), 1082–1083. https://doi.org/10.1016/S1474-4422(09)70298-4
   PubMed Web of Science ®Google Scholar
• Davies, P., & Maloney, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet (London, England), 2(8000), 1403. https://doi.org/10.1016/s0140-6736(76)91936-x
   PubMed Web of Science ®Google Scholar
• Ertl, P., Rohde, B., & Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal of Medicinal Chemistry, 43(20), 3714–3717. https://doi.org/10.1021/jm000942e
   PubMed Web of Science ®Google Scholar
• Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999). The cholinergic hypothesis of Alzheimer’s disease: A review of progress. Journal of Neurology, Neurosurgery, and Psychiatry, 66(2), 137–147. https://doi.org/10.1136/jnnp.66.2.137
   PubMed Web of Science ®Google Scholar
• Frisch, M., Trucks, G., Schlegel, H., Scuseria, G., Robb, M., Cheeseman, J., Scalmani, G., Barone, V., PeTersson, G., & Nakatsuji, H. (2016). Gaussian 16. Gaussian, Inc.
   Google Scholar
• Frost, B., Jacks, R. L., & Diamond, M. I. (2009). Propagation of tau misfolding from the outside to the inside of a cell. The Journal of Biological Chemistry, 284(19), 12845–12852. https://doi.org/10.1074/jbc.M808759200
   PubMed Web of Science ®Google Scholar
• Ganeshpurkar, A., Singh, R., Gore, P. G., Kumar, D., Gutti, G., Kumar, A., & Singh, S. K. (2020). Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors. Molecular Simulation,.46(3), 169–185. https://doi.org/10.1080/08927022.2019.1682572
   Web of Science ®Google Scholar
• Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012). Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/10.1021/cn200100h
   PubMed Web of Science ®Google Scholar
• Ghotbi, G., Mahdavi, M., Najafi, Z., Moghadam, F. H., Hamzeh-Mivehroud, M., Davaran, S., & Dastmalchi, S. (2020). Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease. Bioorganic Chemistry, 103, 104186. https://doi.org/10.1016/j.bioorg.2020.104186
   PubMed Web of Science ®Google Scholar
• Haghighijoo, Z., Zamani, L., Moosavi, F., & Emami, S. (2022). Therapeutic potential of quinazoline derivatives for Alzheimer’s disease: A comprehensive review. European Journal of Medicinal Chemistry, 227, 113949. https://doi.org/10.1016/j.ejmech.2021.113949
   PubMed Web of Science ®Google Scholar
• Hardy, J., & Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends in Pharmacological Sciences, 12(10), 383–388. https://doi.org/10.1016/0165-6147(91)90609-v
   PubMed Web of Science ®Google Scholar
• Harrington, C. R. (2012). The molecular pathology of Alzheimer’s disease. Neuroimaging Clinics of North America, 22(1), 11–22, vii. https://doi.org/10.1016/j.nic.2011.11.003
   PubMed Web of Science ®Google Scholar
• Hassan, H. A., Allam, A. E., Abu-Baih, D. H., Mohamed, M. F. A., Abdelmohsen, U. R., Shimizu, K., Desoukey, S. Y., Hayallah, A. M., Elrehany, M. A., Mohamed, K. M., & Kamel, M. S. (2020). Isolation and characterization of novel acetylcholinesterase inhibitors from Ficus benghalensis L. leaves. RSC Advances, 10(60), 36920–36929. https://doi.org/10.1039/d0ra06565j
   PubMed Web of Science ®Google Scholar
• Heravi, M. M., & Zadsirjan, V. (2020). Prescribed drugs containing nitrogen heterocycles: An overview. RSC Advances, 10(72), 44247–44311. https://doi.org/10.1039/d0ra09198g
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Hu, J., & Wang, X. (2021). Alzheimer’s disease: From pathogenesis to mesenchymal stem cell therapy – Bridging the missing link. Frontiers in Cellular Neuroscience, 15, 811852. https://doi.org/10.3389/fncel.2021.811852
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, J. A. (2013). CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Husain, A., Balushi K, A., Akhtar, M. J., & Khan, S. A. (2021). Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer’s disease. Journal of Molecular Structure. 1241, 130618. https://doi.org/10.1016/j.molstruc.2021.130618
   Web of Science ®Google Scholar
• Ibrar, A., Khan, A., Ali, M., Sarwar, R., Mehsud, S., Farooq, U., Halimi, S. M. A., Khan, I., & Al-Harrasi, A. (2018). Combined in vitro and in silico studies for the anticholinesterase activity and pharmacokinetics of coumarinyl thiazoles and oxadiazoles. Frontiers in Chemistry, 6, 61. https://doi.org/10.3389/fchem.2018.00061
   PubMed Web of Science ®Google Scholar
• Jalili-Baleh, L., Forootanfar, H., Küçükkılınç, T. T., Nadri, H., Abdolahi, Z., Ameri, A., Jafari, M., Ayazgok, B., Baeeri, M., Rahimifard, M., Abbas Bukhari, S. N., Abdollahi, M., Ganjali, M. R., Emami, S., Khoobi, M. E. HDI., & Foroumadi, A. (2018). Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer’s disease based on coumarin and lipoic acid scaffolds. European Journal of Medicinal Chemistry, 152, 600–614. https://doi.org/10.1016/j.ejmech.2018.04.058
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Junaid, M., Islam, N., Hossain, M. K., Ullah, M. O., & Halim, M. A. (2019). Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer’s disease. PloS One, 14(2), e0211935. https://doi.org/10.1371/journal.pone.0211935
   PubMed Web of Science ®Google Scholar
• Kareem, R. T., Abedinifar, F., Mahmood, E. A., Ebadi, A. G., Rajabi, F., & Vessally, E. (2021). The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s agents: Highlights from 2010 to 2020 [https://doi.org/10.1039/D1RA03718H]. RSC Advances, 11(49), 30781–30797. https://doi.org/10.1039/d1ra03718h
   PubMed Web of Science ®Google Scholar
• Khanal, P., Zargari, F., Far, B. F., Kumar, D., R, M., Mahdi, Y. K., Jubair, N. K., Saraf, S. K., Bansal, P., Singh, R., Selvaraja, M., & Dey, Y. N. (2021). Integration of system biology tools to investigate huperzine A as an anti-Alzheimer agent. Frontiers in Pharmacology, 12, 785964. https://doi.org/10.3389/fphar.2021.785964
   PubMed Web of Science ®Google Scholar
• Korabecny, J., Dolezal, R., Cabelova, P., Horova, A., Hruba, E., Ricny, J., Sedlacek, L., Nepovimova, E., Spilovska, K., Andrs, M., Musilek, K., Opletalova, V. E. RONIKA., Sepsova, V., Ripova, D., & Kuca, K. (2014). 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. European Journal of Medicinal Chemistry, 82, 426–438. https://doi.org/10.1016/j.ejmech.2014.05.066
   PubMed Web of Science ®Google Scholar
• Kryger, G., Silman, I., & Sussman, J. L. (1999). Structure of acetylcholinesterase complexed with E2020 (Aricept): Implications for the design of new anti-Alzheimer drugs. Structure (London, England: 1993), 7(3), 297–307. https://doi.org/10.1016/s0969-2126(99)80040-9
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa - A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lan, J.-S., Ding, Y., Liu, Y., Kang, P., Hou, J.-W., Zhang, X.-Y., Xie, S.-S., & Zhang, T. (2017). Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry, 139, 48–59. https://doi.org/10.1016/j.ejmech.2017.07.055
   PubMed Web of Science ®Google Scholar
• Lee, C., Yang, W., & Parr, R. G. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review. B, Condensed Matter, 37(2), 785–789. https://doi.org/10.1103/physrevb.37.785
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Martins, P., Jesus, J., Santos, S., Raposo, L. R., Roma-Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2015). Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine’s tool box. Molecules (Basel, Switzerland), 20(9), 16852–16891. https://doi.org/10.3390/molecules200916852
   PubMed Web of Science ®Google Scholar
• Martorana, A., Giacalone, V., Bonsignore, R., Pace, A., Gentile, C., Pibiri, I., Buscemi, S., Lauria, A., & PicciONello, A. P. (2016). Heterocyclic scaffolds for the treatment of Alzheimer’s disease. Current Pharmaceutical Design, 22(26), 3971–3995. https://doi.org/10.2174/1381612822666160518141650
   PubMed Web of Science ®Google Scholar
• McGeer, P. L., & Rogers, J. (1992). Anti‐inflammatory agents as a therapeutic approach to Alzheimer’s disease. Neurology, 42(2), 447–449. https://doi.org/10.1212/wnl.42.2.447
   PubMedGoogle Scholar
• McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34(7), 939–944. https://doi.org/10.1212/wnl.34.7.939
   PubMed Web of Science ®Google Scholar
• Moodie, L. W., Sepčić, K., Turk, T., Frangež, R., & Svenson, J. (2019). Natural cholinesterase inhibitors from marine organisms. Natural Product Reports, 36(8), 1053–1092. https://doi.org/10.1039/c9np00010k
   PubMed Web of Science ®Google Scholar
• Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., Al Hamad, H., Alahdab, F., Alanezi, F. M., Alipour, V., Almustanyir, S., Amu, H., Ansari, I., Arabloo, J., Ashraf, T., … Vos, T. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 7(2), e105–e125. https://doi.org/10.1016/S2468-2667(21)00249-8
   PubMed Web of Science ®Google Scholar
• Nordberg, A., & Svensson, A.-L. (1998). Cholinesterase inhibitors in the treatment of Alzheimer’s disease. Drug Safety, 19(6), 465–480. https://doi.org/10.2165/00002018-199819060-00004
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England), 29(7), 845–854. https://doi.org/10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Riaz N, Iftikhar M, Saleem M, Aziz ur R, Hussain S, Rehmat F, Afzal Z, Khawar S, Ashraf M, al-Rashida M. 2020. New synthetic 1,2,4-triazole derivatives: Cholinesterase inhibition and molecular docking studies. Results in Chemistry. 2:100041. https://doi.org/10.1016/j.rechem.2020.100041
   Google Scholar
• Rogers, S. L., & Friedhoff, L. T. (1996). The efficacy and safety of donepezil in patients with Alzheimer’s disease: Results of a us multicentre, randomized, double-blind, placebo-controlled Trial. Dementia (Basel, Switzerland), 7(6), 293–303. https://doi.org/10.1159/000106895
   PubMedGoogle Scholar
• Sağlık, B. N., Ilgın, S., & Özkay, Y. (2016). Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes. European Journal of Medicinal Chemistry, 124, 1026–1040. https://doi.org/10.1016/j.ejmech.2016.10.042
   PubMed Web of Science ®Google Scholar
• Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016). Alzheimer’s disease. Lancet (London, England), 388(10043), 505–517. https://doi.org/10.1016/S0140-6736(15)01124-1
   PubMed Web of Science ®Google Scholar
• Shen, L-L., Liu, G-X., & Tang, Y. (2007). Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors. Acta Pharmacologica Sinica, 28(12), 2053–2063. https://doi.org/10.1111/j.1745-7254.2007.00664.x
   PubMed Web of Science ®Google Scholar
• Singh, A., Sharma, S., Arora, S., Attri, S., Kaur, P., Kaur Gulati, H. R. M., Bhagat, K., Kumar, N., Singh, H., Vir Singh, J., & Mohinder Singh Bedi, P. (2020). New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. Bioorganic & Medicinal Chemistry Letters, 30(20), 127477. https://doi.org/10.1016/j.bmcl.2020.127477
   PubMed Web of Science ®Google Scholar
• Singh, K., Pal, R., Khan, S. A., Kumar, B., & Akhtar, M. J. (2021). Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review. Journal of Molecular Structure. 1237, 130369. https://doi.org/10.1016/j.molstruc.2021.130369
   Web of Science ®Google Scholar
• Sugimoto, H., Iimura, Y., Yamanishi, Y., & Yamatsu, K. (1995). Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. Journal of Medicinal Chemistry, 38(24), 4821–4829. https://doi.org/10.1021/jm00024a009
   PubMed Web of Science ®Google Scholar
• Sugimoto, H., Tsuchiya, Y., Sugumi, H., Higurashi, K., Karibe, N., Iimura, Y., Sasaki, A., Araki, S., Yamanishi, Y., & Yamatsu, K. (1992). Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine, and related derivatives. Journal of Medicinal Chemistry, 35(24), 4542–4548. https://doi.org/10.1021/jm00102a005
   PubMed Web of Science ®Google Scholar
• Sugimoto, H., Yamanishi, Y., Iimura, Y., & Kawakami, Y. (2000). Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Current Medicinal Chemistry, 7(3), 303–339. https://doi.org/10.2174/0929867003375191
   PubMed Web of Science ®Google Scholar
• Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991). Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science (New York, N.Y.), 253(5022), 872–879. https://doi.org/10.1126/science.1678899
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H. (2007). Pathogenesis of Alzheimer’s disease. Clin Interv Aging, 2(3), 347–359.
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998). Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. Journal of Drug Targeting, 6(2), 151–165. https://doi.org/10.3109/10611869808997889
   PubMed Web of Science ®Google Scholar
• van Greunen, D. G., Cordier, W., Nell, M., van der Westhuyzen, C., Steenkamp, V., Panayides, J.-L., & Riley, D. L. (2017). Targeting Alzheimer’s disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil. European Journal of Medicinal Chemistry, 127, 671–690. https://doi.org/10.1016/j.ejmech.2016.10.036
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Verma, A., Kumar Waiker, D., Bhardwaj, B., Saraf, P., & Shrivastava, S. K. (2022). The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease. Bioorganic Chemistry, 119, 105562. https://doi.org/10.1016/j.bioorg.2021.105562
   PubMed Web of Science ®Google Scholar
• Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014). Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. Journal of Medicinal Chemistry, 57(24), 10257–10274. https://doi.org/10.1021/jm501100b
   PubMed Web of Science ®Google Scholar
• Więckowska, A., Więckowski, K., Bajda, M., Brus, B., Sałat, K., Czerwińska, P., Gobec, S., Filipek, B., & MALawska, B. (2015). Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Bioorganic & Medicinal Chemistry, 23(10), 2445–2457. https://doi.org/10.1016/j.bmc.2015.03.051
   PubMed Web of Science ®Google Scholar
• Wilcock, G., Howe, I., Coles, H., Lilienfeld, S., Truyen, L., Zhu, Y., Bullock, R., & Kershaw, P. (2003). A long-term comparison of galantamine and Donepezil in the treatment of Alzheimer’s disease. Drugs & Aging, 20(10), 777–789. https://doi.org/10.2165/00002512-200320100-00006
   PubMed Web of Science ®Google Scholar
• World Health Organization: Global health estimates. (2021).
   Google Scholar